Velarion Records
Free. Unsubscribe any time.

Avidity Biosciences, Inc. (RNA)

Avidity Biosciences, Inc. filed 53 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 11 reporting owners, covering 78 transactions and 855,325 shares. None carries the SEC's AFF10B5ONE flag; all 53 name a plan in a footnote. 4 results prints are on file in the same window.

What stands out

Trades in Avidity Biosciences, Inc. 78

Adoption dates in Avidity Biosciences, Inc. 7

Results prints in Avidity Biosciences, Inc. 4

Trades before a print in Avidity Biosciences, Inc. 16

Interval to Avidity Biosciences, Inc.’s next reported results date

How the interval and sources are counted →

Adoption dates Avidity Biosciences, Inc. states

Filing text: “10b5-1 trading plan previously adopted by the Reporting Person on June 12, 2024”

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.